FTSE 100 news / Companies and sectors / Smith & Nephew / 15 October 2026

Smith & Nephew (SN): news on Thursday 15 October 2026

−2.3 slightly negative

Coverage centred on Smith & Nephew cutting its sales outlook, which put the stock under scrutiny. This was partly offset by reports of a cartilage implant launch in Europe and other new product launches.

What drove it

sales outlook cut
cartilage implant launch
November trading update

The 3 stories

Each headline's own score, strongest first. Links go to the publisher.

−9.2 Why Is Smith & Nephew (LSE:SN.) Stock Under Scrutiny After Cutting Its Sales Outlook? Kalkine Media
Cut to sales outlook puts stock under scrutiny.
+7.0 What Smith & Nephew (LSE:SN.)'s Europe Cartilage Implant Launch Means For Shareholders Simply Wall Street
European launch of cartilage implant is a positive product development.
+2.0 FTSE 100 Medtech Group Smith & Nephew (LSE:SN.) New Product Launches Put Its November Trading Update in Focus Kalkine Media
New product launches positive, but trading update brings uncertainty.

Smith & Nephew: every day · Pharma and healthcare on 15 October 2026 · FTSE 100 overview for the day